We have never lived in a time of greater understanding of human genetic makeup and how our genes do not have to determine our destiny.
In Conversation
Quality is an aspect in which we excel, we say "quality first and safety always". It is key because there is a patient at the end…
Hungary is a good position as it has the luxury to observe the best practices of the first adopters such as the United States and Europe.
As a company we are committed to environmental excellence, continuous improvement and sustainability, which are key elements to keep our Puerto Rico operations running and growing.
My message is that the island has a huge research capacity, with a well-trained medical community eager to become part of the development of new and…
Domestic centralized health care and the presence of a single central ethics committee opinion all contribute to the success of clinical trials in Hungary. Currently, Hungary…
Hurricane Maria put us in a delicate situation, but it also brought an opportunity to do something meaningful.
Our main priorities are still the same: to ensure sustainability and increase predictability in highly regulated market conditions.
Hungary has the knowledge and capacity to produce global innovations.
Cell and gene therapy is an extremely complex area and unlike pharmaceutical drugs, there tends to be a lot of process-specific know-how and manual expertise required.
We are developing products for conditions that affect hundreds of millions, perhaps billions of people around the world.
Today's partnerships, framework, committees, and bioethical codex could not exist without building on top of predecessors.
